Individuals with TREM2 risk variants were more likely to have atypical nonamnestic AD clinical phenotypes, which correlated with a higher proportion of cases with an atypical, hippocampal sparing distribution of NFTs (17). This evidence concerns the gene TREM2 and Alzheimer disease.